Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

Recruiting

Phase 3

Givinostat vs. HydroxyureaStudy on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

Sponsor:

Italfarmaco

Code:

NCT06093672

Conditions

Polycythemia Vera

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Givinostat

Hydroxyurea

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-01. This information was provided to ClinicalTrials.gov by Italfarmaco on 2026-01-27.